Glucose control and vascular complications in veterans with type 2 diabetes - Wikidata - awgldk - TriplyDB

Glucose control and vascular complications in veterans with type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

http://www.wikidata.org/entity/Q29619213

about

Autonomic neuropathy in diabetes mellitus Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations Use of metformin in the setting of mild-to-moderate renal insufficiency ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary Intensive versus conventional glycaemic control for treating diabetic foot ulcers Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Pramlintide for diabetes mellitus Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease Glucose targets for preventing diabetic kidney disease and its progression Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus Insulin for glycaemic control in acute ischaemic stroke Glucose lowering therapies for chronic kidney disease and kidney transplantation Colesevelam for type 2 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Enhanced glucose control for preventing and treating diabetic neuropathy Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Pramlintide for diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein Standards of medical care in diabetes--2012 Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?Interactions between kidney disease and diabetes: dangerous liaisons A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?The EMPA-REG outcome study: critical appraisal and potential clinical implications Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report Diabetes Dyslipidemia Updates in diabetic peripheral neuropathy Sodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metformin Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?Treatment of prediabetes Glycemic Targets in Diabetes Care: Emerging Clarity after Accord Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements

P2860

Q21131270-6FB8B222-7401-47F7-A0FC-2A118A48A4B8 Q22241134-B1314F78-3334-44F3-8256-014C42473723 Q22241290-7EBA08E4-5367-4E9E-8062-2B4661F5A4DE Q22241786-6FBAF94C-5CF1-4044-8656-1AE73D7114ED Q24186487-EA99DA0F-4EC5-4C26-ACCF-7440F32C4838 Q24186667-4BAF9BC9-A338-404B-B115-7F4E90B62425 Q24186857-41482537-4D36-41ED-8F6D-E192B5D88E46 Q24188192-A9FC7454-FC15-4845-A709-AA3CEA668E2C Q24198925-0EB09C94-DA4A-43B0-923D-6ED9E2FE5317 Q24200376-01DD8036-D4EA-4B73-AD00-E7064863E78A Q24201046-C45B4620-D1B2-415C-B79C-CD1A41C82474 Q24201814-25F2C311-019A-47AD-BF2E-8DDAA8C2CE3A Q24202334-8C05079A-4B7F-495D-AE21-0377948C3E1D Q24202505-FFDCD9E2-6131-48AD-8318-76E92B84252C Q24202790-5F476C63-6954-4AD5-970A-C2914720ACA1 Q24234960-F9501949-7428-4715-A05B-84D5F0FFA3BF Q24236456-98CADA0D-11FB-4DF4-B11B-BA02C3792F38 Q24240172-39FB2A36-03D3-4802-9FA0-28162D50798D Q24241529-9B93D0B5-F995-4202-BC24-C587586007DD Q24628988-79963C82-9ABD-4B5F-AD03-3A1B4AC0497B Q24629341-C8A97917-561D-4F51-9DB2-3549B9744AEC Q24632533-F5A8DF52-F22D-4287-9AC9-3A15CAC734D2 Q26740247-A9DA6778-0D4E-46CC-AD58-74A2D56CB576 Q26740630-20888825-CC98-471B-84FE-929D5FF81113 Q26744229-05D4DC7D-0356-461F-B0AC-8C6AC16DED2C Q26744419-6A056961-6AE9-458D-B181-BE8D0D55561E Q26745606-3A994112-FA82-434E-917F-D7CBA89775D7 Q26748742-BA566759-83AF-48FD-A865-47029B1F2DD5 Q26749362-917113F6-44CB-4208-AAEF-93FD457BFE27 Q26750905-F9363991-4AAA-4C90-8EB0-364255D79D7F Q26751252-B6A7894F-7FB9-41A8-9C15-54F64F0F6B7F Q26752815-19267B6F-2DE6-4DE9-886B-A226F4182799 Q26767164-5D704E42-FB1F-485E-A109-E720BD941638 Q26767283-5782164C-42B2-4ED0-8420-14DE907CD6F2 Q26774021-AE2A77FE-8406-4CF6-A8B0-0FC64D20DBB6 Q26777994-D975FBAA-1FF1-423F-8841-E0600EBD1194 Q26783350-65F81757-F5E1-47DB-A335-B8878A4E1B76 Q26795380-3DE25DBF-A3A0-4502-B41F-8663E8328995 Q26799903-D1A41130-5C5C-4A52-89B0-765D6F2A79C9 Q26801121-2084AF02-0CB9-4688-8351-A642AC84DF9A

P2860

Glucose control and vascular complications in veterans with type 2 diabetes

http://www.wikidata.org/entity/Q29619213

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Glucose control and vascular complications in veterans with type 2 diabetes

@ast

Glucose control and vascular complications in veterans with type 2 diabetes

@en

type

label

Glucose control and vascular complications in veterans with type 2 diabetes

@ast

Glucose control and vascular complications in veterans with type 2 diabetes

@en

prefLabel

Glucose control and vascular complications in veterans with type 2 diabetes

@ast

Glucose control and vascular complications in veterans with type 2 diabetes

@en

P1433

Q29619213-D34E45CE-89E0-47E3-A120-593720877350

P1476

Q29619213-5AE240FD-BDC0-4C05-AB5D-8989ED9DA4A7

P2093

Q29619213-07DD46C3-310F-462D-B526-E00C75F41A1A

Q29619213-17EF93C9-1478-4A35-91B9-27A58A82529D

Q29619213-1B17AB3F-2F7E-4372-8469-EDDAC3A20454

Q29619213-27C721E8-EAF6-4FC7-8FD2-FCC6D86F70F2

Q29619213-35DFB325-7BB4-44DA-9E49-63790ADF8378

Q29619213-54526A56-DD72-4766-99F7-5B0F01FD2195

Q29619213-65CF4DA1-0066-4F68-B606-F645E9B95C54

Q29619213-81EDF519-C509-4497-99D9-3953E4C84327

Q29619213-9766F83B-6B01-4197-BDAF-30D469C424E0

Q29619213-9AE5AC8E-D419-40A6-9D34-4B0B94EACB93

P304

Q29619213-A3E5EB54-C8D5-4486-80C1-3C4A5EEEE6C0

P31

Q29619213-4CDF5A1A-48EC-4CD5-AD39-32B2076A5161

P3181

Q29619213-9703FCEE-961B-4E70-9AD4-2478CA78A221

P356

Q29619213-19A2235A-031C-4711-946A-F26A7D896116

P407

Q29619213-4FD782D8-9174-448E-9978-DB3217F6A2A6

P433

Q29619213-8C3B4C1A-15F7-411B-9503-6849F7F914A6

P478

Q29619213-4EE3E617-2D9F-4A30-A179-77DDB1261803

P577

Q29619213-DB6410D2-D073-4A6C-824C-12E83C7DA0B0

P5875

Q29619213-7ABF9A04-6CFF-41B8-B352-8F70634E6184

P698

Q29619213-14BE2439-CA73-4730-8CBB-8F5A3B5EC20C

P921

Q29619213-8370B0F2-8150-4E7C-97B6-6547A51D1745

Q29619213-B31E3AE8-AAEF-4972-B997-526EDB4ABE4B

Q29619213-f4e47cd7-bd91-451c-a007-d183c11eb556

P3181

P356

P1433

The New England Journal of Medicine

P1476

Glucose control and vascular complications in veterans with type 2 diabetes

@en

P2093

Abraira C

http://www.w3.org/2001/XMLSchema#string

Davis SN

http://www.w3.org/2001/XMLSchema#string

Duckworth W

http://www.w3.org/2001/XMLSchema#string

Emanuele N

http://www.w3.org/2001/XMLSchema#string

Goldman S

http://www.w3.org/2001/XMLSchema#string

Hayward R

http://www.w3.org/2001/XMLSchema#string

Henderson WG

http://www.w3.org/2001/XMLSchema#string

Huang GD

http://www.w3.org/2001/XMLSchema#string

Marks J

http://www.w3.org/2001/XMLSchema#string

McCarren M

http://www.w3.org/2001/XMLSchema#string

P304

129-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

19368

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0808431

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23673190

http://www.w3.org/2001/XMLSchema#string

P698

19092145

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes